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Abstract 
 
During musculoskeletal development, Sry-type HMG box 9 (Sox9) has a crucial role in mesenchymal 
condensation and chondrogenesis. On the other hand, a tissue-specific basic helix-loop-helix (bHLH) 
transcription factor Scleraxis (Scx) regulates the differentiation of tendon and ligament progenitors. 
Whereas these two transcription factors cooperatively participate in the determination of cellular 
lineages, the precise interaction between Sox9 and Scx remains unclear. We have previously 
demonstrated that the Sox9-dependent transcription is synergistically activated by several Sox9-
associating molecules, such as p300 and Smad3, on chromatin. In this study, we investigated the 
function of Scx in the Sox9-dependent transcription. The expression of α1(II) collagen (Col2a1) gene 
was stimulated by an appropriate transduction of Sox9 and Scx. Scx and its partner E47, which 
dimerizes with other bHLH proteins, cooperatively enhanced the Sox9-dependent transcription in 
luciferase reporter assays. Coactivator p300 synergistically increased the activity of Sox9-regulated 
reporter gene, which contains promoter and enhancer regions of Col2a1, in the presence of Scx and 
E47. Immunoprecipitation analyses revealed that Scx and E47 formed a transcriptional complex with 
Sox9 and p300. Scx/E47 heterodimer also associated with a conserved E-box sequence (CAGGTG) in 
the Col2a1 promoter on chromatin. These findings suggest that Scx and E47 might modulate the 
primary chondrogenesis by associating with the Sox9-related transcriptional complex, and by binding 
to the conserved E-box on Col2a1 promoter. 
 
Keywords: E47; p300; Scleraxis; Sox9; Transcription 
 
The abbreviations used are: AD, activation domain; bHLH, basic helix-loop-helix; BMP, bone 
morphogenetic protein; Col2a1, α1(II) collagen; EMSA, electrophoretic mobility shift assay; FGF, 
fibroblast growth factor; G3PDH, glyceraldehyde-3-phosphate dehydrogenase; bHLH, basic helix-
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loop-helix; IP, immunoprecipitation; Scx, Scleraxis; siRNA, small interfering RNA; Sox9, Sry-type 
HMG box 9; TGF, transforming growth factor; WB, Western blot. 
 
1. Introduction 
 
A functional musculoskeletal system depends on the coordinated development of bone, cartilage, 
tendon, and muscle. During somite development, the interactions between myotome and sclerotome 
have crucial roles in the formation of syndetome, a somitic compartment of Scleraxis (Scx)-
expressing tendon progenitors (Brent et al., 2003). Fibroblast growth factor (FGF) signals from 
muscle progenitors (myotome) induce syndetome. On the other hand, cartilage progenitors 
(sclerotome) indirectly suppress the Scx expression in tendon progenitors (Brent et al., 2003). In 
embryonic development, a class II basic helix-loop-helix (bHLH) transcription factor Scx and a Sry-
type HMG box 9 (Sox9) coordinately regulate the process of cellular differentiation in mesenchymal 
progenitors (Asou et al., 2002). However, the precise interaction between these two transcription 
factors in the determination of different cellular lineages, such as tendon and chondrocyte precursor 
cells, has not been fully elucidated. 
 
Sox9, which encodes a HMG DNA-binding domain, has been identified as a master transcription 
factor in chondrogenesis (Kamachi et al., 2000). Heterozygous mutations in Sox9 cause the skeletal 
malformation syndrome, campomelic dysplasia (Foster et al., 1994; Wagner et al., 1994). Sox9 
regulates the expression of its target genes by through the association with the consensus DNA 
sequences (WWCAAWG) on promoters or enhancers of cartilage-specific genes, such as α1(II) 
collagen (Col2a1), α1(IX), α2(XI) collagen, aggrecan, cartilage link protein, and Cd-rap (Bell et al., 
1997; Bridgewater et al., 1998; Xie et al., 1999; Sekiya et al., 2000; Zhang et al., 2003; Kou and 
Ikegawa, 2004). We have previously reported that the Sox9-dependent transcription is synergistically 
activated by cofactor p300, Smad3, and PGC-1α in chondrogenesis (Tsuda et al., 2003; Furumatsu et 
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al., 2005a; Kawakami et al., 2005). In addition, the Sox9-related transcriptional complex has an 
important role in the epigenetic regulation during chondrogenesis. Transforming growth factor (TGF)-
β receptor-regulated Smad3 and p300, which has an intrinsic histone acetyltransferase activity, 
cooperatively enhance the Sox9-dependent transcription on chromatin through the acetylation of 
histones (Furumatsu et al., 2005b, 2009). These findings suggest that Sox9-associating molecules 
should modulate the Sox9-regulated chondrogenesis on chromatin. 
 
Scx is a distinct marker for tendon and ligament progenitors (Schweitzer et al., 2001). Scx 
homozygous mutant embryos are unable to form mesoderm and to gastrulate (Brown et al., 1999). 
Conditional knockout mice of Scx gene show a failure in the condensation of tendon progenitors and 
a severe disruption of force-transmitting and intermuscular tendons (Murchison et al., 2007). We have 
previously demonstrated that Scx positively regulates the expression of tenomodulin, a marker of 
tendon formation (Shukunami et al., 2006). Several authors have also indicated that Scx is a key 
transcription factor to regulate the transcription of aggrecan, α1(I), and α2(I) collagen genes (Liu et 
al., 1997; Terraz et al., 2002; Lejard et al., 2007; Espira et al., 2009). The tissue-specific bHLH 
transcription factor Scx interacts with cis-acting elements (CANNTG), called E-boxes, in the 
promoter regions of target genes as a Scx/E47 heterodimer (Liu et al., 1997; Carlberg et al., 2000; 
Terraz et al., 2002; Lejard et al., 2007; Espira et al., 2009). E47 is an alternative splice variant of the 
E2A gene, a class I ubiquitous bHLH protein. E47 dimerizes with a class II bHLH protein, such as the 
myogenic bHLH MyoD, by through each bHLH domain (Lu and Sloan, 2002). Class I/II bHLH 
heterodimers strongly activate the transcription of their target genes by binding to specific E-box 
sequences, rather than bHLH homodimers (Massari and Murre, 2000). In our previous study, we 
described that the recruitment of p300 may have a critical role for the synergistic activation of insulin 
promoter by the BETA2/E47 heterodimer (Amemiya-Kudo et al., 2005). Several reports have shown 
that the associations between E2A and p300 coactivators are important in many cellular responses, 
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such as proliferation, differentiation, and transcriptional activation (Qiu et al., 1998; Bradney et al., 
2003; Bayly et al., 2004). However, the crosstalk among Scx, E47, and p300 is still unclear. 
 
Here, we hypothesized that Scx and E47 might modulate the Sox9-dependent transcription through 
the association with Sox9-associating cofactor p300. In the present study, we investigated the 
interaction among Sox9, Scx, E47, and p300. Our study demonstrates that Scx and E47 cooperatively 
activate the Sox9-dependent Col2a1 expression by associating with the Sox9-p300 transcriptional 
complex, and by binding to a conserved E-box sequence in the Col2a1 promoter on chromatin. 
 
2. Materials and methods 
 
2.1. Cells, plasmids, and antibodies 
A human chondrosarcoma cell line (SW1353) was used as an immature chondrogenic cell line. 
Plasmids encoding full-length (1-507 amino acids) and partial fragments (1-327, 1-423, 182-507 
amino acids) of rat Sox9 were used (Furumatsu et al., 2005a). Expression plasmids of mouse Scx and 
rat E47 (full length, dAD1/2, dHLH) have been described previously (Amemiya-Kudo et al., 2005; 
Shukunami et al., 2006). p300 was a gift from Tso-Pang Yao. pGL3-585, which contains a mouse 
Col2a1 promoter extending from -585 to +73 bp of the transcription start site, was constructed with a 
pGL3-Basic vector (Promega). The site-directed mutation (-caggtg- to -caggAA-, in capital letters) on 
a conserved E-box (from -577 to -572 bp) was inserted (pGL3-585M). pGL3-569, which lacks the 
conserved E-box, was also constructed. The reporter plasmid containing Sox9-binding enhancer, 
pGL3-585E, was used as described (Furumatsu et al., 2009). The following antibodies were used: 
E2A Yae (Santa Cruz), β-actin, HA, HA affinity gel, FLAG M2, and FLAG M2 affinity gel (Sigma). 
 
2.2. Transfection, small interfering RNA (siRNA), RT-PCR, and quantitative real-time PCR 
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Plasmids were transiently transfected using FuGENE6 (Roche) according to the manufacturer’s 
protocol. Transfected cells were cultured for 24 h. A common siRNA against human/mouse Scx (si-
Scx, 5’- CGCAC CAACA GCGUG AACAT T -3’ and 5’- UGUUC ACGCU GUUGG UGCGT T -3’) 
and Silencer select negative control siRNA (Ambion) were occasionally transfected using 
Oligofectamine (Invitrogen) after plasmid transfections. siRNA-transfected cells were harvested for 
48 h. Total cellular RNAs were extracted using QuickGene SP kits (Fujifilm). Reverse transcribed 
cDNAs were subjected to PCR amplification (Date et al., 2009). Quantitative real-time PCR analyses 
were also performed using FastStart DNA Master SYBR Green I kit (Roche) according to the 
manufacturer’s protocol. The primer sets for human SOX9, rat Sox9, human SCX, mouse Scx, human 
E47, rat E47, human COL2A1, and human glyceraldehyde-3-phosphate dehydrogenase (G3PDH) are 
shown in Table 1. PCR reactions were allowed to proceed for 27-33 cycles. These assays were run in 
triplicate and relative mRNA expressions were calculated as described (Tetsunaga et al., 2009). 
 
2.3. Luciferase reporter assay 
To assess the Sox9-dependent transcriptional activity, Gal4-TK Luc reporter and Gal4-Sox9 
constructs were used (Furumatsu et al., 2005a). pGL3-585, 585M, 569, and 585E were used as native 
Col2a1 reporter genes. Appropriate plasmids (50 ng) and/or si-Scx were transiently transfected into 
SW1353 cells using FuGENE6. pRL-CMV (10 ng, Promega) was used as an internal control. The 
cells were harvested for 24 hr, and then the luciferase activities were analyzed using Dual-Luciferase 
Reporter Assay System (Promega). The assays were performed in triplicate. 
 
2.4. Immunoprecipitation (IP), nuclear extraction, and Western blot (WB) 
Transiently transfected SW1353 cells (500 ng of each plasmid/3.5-cm dish) were harvested for 24 h. 
Cell extracts were prepared with IP buffer 0 (Furumatsu et al., 2005a). Ten percent volume of 
supernatant was loaded as an input fraction. Forty-five percent volume of extract was incubated with 
FLAG M2 or HA affinity gel for 1 hr at 4°C. The remaining supernatant was incubated with mouse 
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IgG and protein G beads (Sigma) as a control. Cytoplasmic fractions and nuclear extracts of SW1353 
cells were prepared in buffer A and B, respectively, as described (Furumatsu et al., 2005a). Protein 
concentrations were measured by BCA protein assay kit (Bio-Rad). Western blot analyses were 
performed as described (Tsuda et al., 2003). 
 
2.5. Electrophoretic mobility shift assay (EMSA) 
The conserved E-box (in capital letters)-containing probe, -577 E-box probe, was generated by 
annealing the following oligonucleotides: 5’-cgaga ctcCA GGTGg gagct cac-3’ and 5’-gtgag ctccC 
ACCTG gagtc tcg-3’. Probes were end-labeled using Biotin 3’ end DNA labeling kit (Pierce). Binding 
reactions and detections were performed with 5 μg of SW1353 nuclear extracts and 20 fmol of end-
labeled probe using LightShift chemiluminescent EMSA kit (Pierce) according to instructions. The 
unlabeled probe (400 fmol) was used as a competitor. 
 
2.6. Chromatin immunoprecipitation 
Chromatin IP assays were performed as described previously (Furumatsu et al., 2005a). In brief, 
SW1353 cells were transfected with indicated plasmids (2 μg/10-cm dish). Cell lysates were 
suspended in nuclear lysis buffer. Ten percent volume of each supernatant was stocked as an input 
sample. Half of each remaining sample was incubated with indicated antibodies. Immunoprecipitated 
DNAs were purified, and then PCR reactions were allowed to proceed for 27 cycles. The following 
primers were used to amplify the conserved E-box in COL2A1 promoter: 5’-CAGCT CTTTT CCTGG 
CTGTC-3’ and 5’-CCCCG ACCTA TCTTT TAGCC-3’. 
 
2.7. Statistical analysis 
All experiments were repeated at least three times and similar results were obtained. Data were 
expressed as means. Differences among groups were compared by using the Mann-Whitney U-test. 
Statistical significance was established at p < 0.05. 
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3. Results 
 
3.1. Sox9, Scx, and E47 cooperatively stimulate the expression of COL2A1 gene. 
We firstly assessed the expression pattern of COL2A1 gene, a chondrogenic marker, under different 
balances between Sox9 and Scx. An individual transfection of Sox9 or Scx did not stimulate COL2A1 
expression in quantitative real-time PCR analyses. However, a simultaneous transfection of Sox9 and 
Scx increased COL2A1 expression up to a 2.9-fold level of control in an immature chondrogenic cell 
line, SW1353 cells (Fig. 1, A and C). The increase of COL2A1 expression was enhanced up to a 5.5-
fold level of control by the cotransfection of E47 (Fig. 1, B and D). In addition, the interfering 
analyses using si-Scx revealed that excessively high and low transduction of Scx did not increase the 
expression of endogenous SOX9 and COL2A1 (Fig. 2). COL2A1 expression was increased up to a 
2.1-fold level of control in an appropriate balance between endogenous SOX9 (higher than Scx) and 
overexpressed Scx (lower than SOX9, 40 pmol of si-Scx). Endogenous gene expressions of SOX9, 
SCX, and E47 in human chondrocytic cells, such as SW1353 cells, a differentiated chondrosarcoma 
cell line OUMS-27 (Furumatsu et al., 2002; Kunisada et al., 1998), and human chondrocytes, were 
also shown in Supplemental Fig. 1.  
 
3.2. Scx and E47 regulate the Sox9-dependent transcription. 
To elucidate the transcriptional cross-talk among Sox9, Scx, and E47, we investigated the Sox9-
dependent transcription using Gal4-TK luciferase reporter assays. Scx and E47 did not show any 
effects in the absence of Gal4-Sox9 (Fig. 3A, Gal4). However, a simultaneous transfection of Scx and 
E47 increased a relative luciferase activity up to a 7.3-fold level of Gal4 control in the presence of 
Gal4-Sox9 encoding the full length of Sox9 (Fig. 3A, Gal4-Sox9 1-507). We also examined the 
effects of coactivator p300 in this system. The activity of mutant Gal4-Sox9 1-327, which lacks the 
binding region to p300, was not influenced by the addition of Scx, E47, and p300 (Fig. 3B). On the 
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other hand, Scx, E47, and p300 synergistically enhanced the transcriptional activity of Gal4-Sox9 1-
507 to a level as high as 29-fold over the Gal4 control (Fig. 3B). This synergistic effect was not 
observed by E47 deletion mutants. E47 dAD1/2, lacking the binding region to the KIX domain of 
p300, did not induce the additional enhancement of Scx and p300 (Fig. 3C, E47 dAD1/2). Deletion 
mutant lacking bHLH domain of E47 also showed no synergistic effect in the presence of Scx and 
p300 (Fig. 3C, E47 dHLH). These findings suggest that Scx and E47 might regulate the Sox9-
dependent transcription through the association with Sox9 and p300. 
 
3.3. E47 associates with Sox9, Scx, and p300. 
E47 directly interacts with CREB-binding protein (a close paralog of p300) in hematopoietic cells 
(Bayly et al., 2004; Bradney et al., 2003). E47 also forms a heterodimer with Scx in tendon fibroblasts 
(Carlberg et al., 2000; Lejard et al., 2007). In our previous studies, Sox9 directly associates with p300 
(Furumatsu et al., 2009; Tsuda et al., 2003). Here, we investigated the protein interactions among 
Sox9, p300, E47, and Scx to understand the cooperative effects of Scx and E47 in the Sox9-dependent 
transcription. Coactivator p300 associated with Sox9 and E47 in SW1353 cells (Fig. 4A). We also 
observed that E47 had an ability to interact with Sox9 in the presence or absence of p300 (Fig. 4B). IP 
analyses using truncated constructs revealed that the P/Q rich domain of Sox9 (encoding 328-423 
amino acids) was necessary for the association between Sox9 and E47 (Fig. 4C). The complex 
formation between Scx and E47 predictably depended on the bHLH domain of E47 (Fig. 4D). 
Whereas the direct interaction between Sox9 and Scx was not detected, Scx was partly 
coimmunoprecipitated with Sox9 in the presence of transfected E47 (Fig. 4E). 
 
3.4. Scx and E47 modulate the Sox9-dependent transcription by a putative E-box on Col2a1 promoter. 
We searched putative E-box sequences on Col2a1 promoters in several species. Conserved putative E-
boxes were found at approximately 580-bp and 150-bp upstream from the transcription start site of 
Col2a1 genes (Fig. 5A). To investigate the function of Scx and E47 on Col2a1 promoter, we 
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constructed the indicated reporter plasmids (Fig. 5B). Scx and E47 cooperatively stimulated the 
relative luciferase activity of pGL3-585 up to a 2-fold level of control (Fig. 5C). However, the 
cooperative effect of Scx and E47 was not observed in pGL3-585M and pGL3-569 (Fig. 5C). Scx, 
E47, and p300 synergistically increased the transcriptional activity of pGL3-585E, which encodes the 
Sox9-binding enhancer, up to an 11.3-fold level of control in the presence of Sox9 1-507 (Fig. 5D). 
These findings prompted us to investigate the interaction between Scx, E47, and the conserved E-box 
sequence on Col2a1 promoter (-577 to -572 bp). 
 
3.5. Scx-E47 transcriptional complex associates with the -577 E-box on Col2a1 promoter. 
Overexpressed Scx was abundantly detected in the nuclear fractions of SW1353 cells (Fig. 6A). 
Protein-DNA complexes were not detected by a single transfection of Scx or E47 in EMSA (Fig. 6B, 
Scx, E47). On the other hand, the -577 E-box containing probes formed a complex with the nuclear 
extract purified from Scx and E47-cotransfected cells (Fig. 6B, Scx + E47). Unlabeled competitors 
decreased the bindings between proteins and biotin end-labeled probes (Fig. 6B, Scx + E47, Compete). 
Chromatin IP analyses revealed that Scx associated with the conserved E-box region of COL2A1 
promoter on chromatin in the presence of E47 (Fig. 6C). Our results indicated that Scx-E47 
transcriptional complex might have a crucial role to regulate the Sox9-dependent transcription 
through the interaction with Sox9, p300, and the E-box sequence on Col2a1 promoter. 
 
4. Discussion 
 
The present study indicated that Scx, E47, and p300 cooperatively activated the Sox9-dependent 
transcription. Scx-E47 complex might have dual effects to modulate the Sox9-dependent Col2a1 
expression: (i) by associating with Sox9 and p300, (ii) and by recognizing the conserved E-box 
sequence on Col2a1 promoter (Fig. 7). We revealed that E47 mediated the formation of Sox9-related 
transcriptional complex through the direct association with Scx, p300, and Sox9 (Fig. 4). In addition, 
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p300 associated with E47 and Sox9 (Fig. 4A) as described previously (Bayly et al., 2004; Tsuda et al., 
2003). From these results, the Sox9-dependent Col2a1 expression might be affected by the balance 
among Sox9-p300, Scx-E47-p300, and Sox9-Scx-E47-p300 complexes. Coactivator p300 acts as a 
bridging factor for connecting DNA-binding transcription factors to the transcriptional apparatus, and 
as a protein scaffold to form multicomponent transcriptional complexes (Utley et al., 1998; Chan et al., 
2001). In addition, we have reported that the histone acetyltransferase activity of p300 facilitates the 
Sox9-dependent transcription on chromatin by histone modification (Tsuda et al., 2003; Furumatsu et 
al., 2005b, 2009). These findings suggest that the Col2a1 expression might be epigenetically regulated 
by Sox9-p300 and/or Sox9-Scx-E47-p300 transcriptional complexes on chromatin. 
 
The discrepancy between SOX9 and COL2A1 expression was observed in the presence of si-Scx (Fig. 
2). Overexpressed Sox9 actually increases the transcriptional activity of Col2a1 reporter gene in 
luciferase assays as described previously. However, the Col2a1 mRNA expression does not seem to be 
sufficiently induced by a single transduction of Sox9 (Li et al., 2004; Hardingham et al., 2006). The 
combination of Sox genes, coactivators, and intracellular signals are necessary for chondrogenesis 
including Col2a1 expression in the presence of Sox9 (Ikeda et al., 2004; Furumatsu et al., 2005a, 
2005b, 2009; Suzuki et al., 2006). In addition, cellular lineages and differentiation stages influence the 
Sox9-dependent transcription (Kypriotou et al., 2003; Hardingham et al., 2006). In our study, 
excessively high and low transduction of Scx did not increase the expression of endogenous SOX9 
and COL2A1 (Fig. 2). We consider that the Col2a1 expression is enhanced by an optimum balance 
between Sox9 and Scx in early chondrocytic SW1353 cells. An appropriate amount of Scx, lower than 
that of Sox9, might stimulate Col2a1 expression by modulating the Sox9 expression itself in an early 
chondrogenesis.  
 
Several transcription partners such as Sox5/6 (Ikeda et al., 2004; Lefebvre et al., 2001), Barx2 (Meech 
et al., 2005), β-catenin (Akiyama et al., 2004; Bernard et al., 2008), c-Maf (Huang et al., 2002), PIAS 
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(Hattori et al., 2006), and TRAP230 (Zhou et al., 2002) can modify the Sox9-dependent transcription 
in chondrogenesis and sex determination. Sox9 is necessary for mesenchymal condensations, and 
considered to be a key transcription factor for the following expression of Sox5/6 genes (Akiyama et 
al., 2002). However, Sox9-/- mouse embryonic stem cells successfully form early condensations 
expressing chondrogenic marker genes such as Sox5/6 and Scx (Hargus et al., 2008). On the other 
hand, the single gene transduction of Sox9 fails to induce a sufficient chondrogenesis (Ikeda et al., 
2004). These reports suggest that the Sox9-regulated coordinated chondrogenesis largely depends on 
cooperative actions of Sox9-associating molecules. Brent et al. (2005) has described that Sox9-
induced Sox5/6 inhibit the expression of Scx to block the differentiation towards tendon and ligament 
cell lineages. In our study, Sox9 transduction did not inhibit the effect of Scx in luciferase reporter 
assays (Fig. 3 and 5D). We also demonstrated that a simultaneous transfection of Sox9 and Scx 
enhanced the COL2A1 expression and the Col2a1 reporter activity, especially in the presence of E47 
and p300 (Fig. 1, 3, and 5). Several authors have indicated that common mesenchymal precursor cells 
expressing both Sox9 and Scx are involved in the coordinated development of cartilages, tendons, and 
ligaments (Asou et al., 2002; Cserjesi et al., 1995). In the limb buds, diversification of cartilage and 
tendon cell lineages is regulated by antagonism between bone morphogenetic protein (BMP) and FGF 
signaling pathways (Brent and Tabin, 2002). BMP-2 not only promotes chondrogenesis, but also 
inhibits tendon development, while FGF-4 has the opposite effect (Edom-Vovard et al., 2002). The 
BMP inhibitor Noggin represses the expression of Sox9 while inducing the Scx expression 
(Schweitzer et al., 2001). In valvulogenesis, similar antagonistic relationships between BMP and FGF 
are also observed (Lincoln et al., 2006a, 2006b). In addition, increased or decreased levels of 
phosphorylated ERK, a MAPK signal transduction cascade of FGF, result in the loss of Scx 
transcripts and rib development (Smith et al., 2005). These findings suggest that the balance between 
Sox9 and Scx should play an important role to determine the lineages of mesenchymal and valve 
progenitor cells. In the early phase of embryonic development, the expressions of Scx and Sox9 are 
overlapped in sclerotome. However, Scx is reduced in the center of Sox9-expresssed sclerotome 
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during the following development (Asou et al., 2002). On the other hand, Scx expression is transiently 
increased in the early stage of embryonic stem cell-derived chondrogenesis (zur Nieden et al., 2005). 
In Scx-/- mutant mice, the deltoid tuberosities that act as the tendon-to-bone interfaces are not 
observed (Murchison et al., 2007). We consider that Scx and Sox9 could be involved in an early 
switch for the initiation of chondrogenic differentiation. The interaction between Scx and Sox9 might 
be not only synergistic in the early chondrogenesis but also antagonistic in the following development 
toward distinct cellular lineages. Further investigations will be required to understand the precise 
mechanism of chondrogenesis regulated by the interaction between Scx and Sox9. 
 
In conclusion, the present study demonstrates that Scx/E47 modulates the Sox9-dependent Col2a1 
expression by associating with Sox9-p300 transcriptional complex, and by binding to the conserved 
E-box on Col2a1 promoter. Our results suggest that the chondrogenic differentiation is delicately 
regulated by the balance between Sox9 and Scx. 
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Figure legends 
 
Fig. 1. Sox9, Scx, and E47 cooperatively activate the COL2A1 expression. 
(A) Different balances of rat Sox9 and mouse Scx transductions were indicated as triangular boxes (0, 
250, and 500 ng/3.5-cm dish). Transient transfection using both Sox9 and Scx (250 ng each) increased 
the COL2A1 expression in SW1353 cells. 
(B) Rat E47 (250 ng) were cotransfected with different volumes of Sox9 and Scx. The COL2A1 
expression was stimulated by cotransfection of Sox9, Scx, and rE47. Endogenous gene expressions 
(human SOX9, SCX, and E47) were also included using universal primer sets (Table 1) in SW1353 
cells. 
(C and D) Relative COL2A1 expressions were determined by quantitative real-time PCR analyses as 
described in Materials and methods. Cotransfection of Sox9 and Scx increased the COL2A1 
expression to a 2.9-fold level of untransfected cells in the absence of rE47 transduction (C). Sox9, Scx, 
and rE47 cooperatively enhanced the COL2A1 expression up to a 5.5-fold level of control (D). * 
Statistical significances (p < 0.05) were observed in the Sox9/Scx-cotransfected cells using Mann-
Whitney U test. 
 
Fig. 2. The expression balance between SOX9 and Scx is important for the COL2A1 
transactivation. 
Mouse Scx (500 ng) and/or si-Scx (0, 20, 40, and 80 pmol/3.5-cm dish, indicated as triangular boxes) 
were transfected in SW1353 cells. Scx transduction was inhibited by si-Scx in a dose-dependent 
manner. Quantitative real-time PCR analyses demonstrated that approximately 20, 30, and 70% of 
interferences in mScx and SCX expressions were observed by 20, 40, and 80 pmol of si-Scx, 
respectively (C). On the other hand, the expression of endogenous SOX9 was stimulated to a 6.2-fold 
level of control by 40 pmol of si-Scx (A and B). Relative COL2A1 expression was increased up to a 
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2.1-fold level of control in an appropriate balance between SOX9 and Scx (40 pmol of si-Scx, A and 
D). * Statistical significances (p < 0.05) compared with each 0 pmol control. 
 
Fig. 3. Scx, E47, and p300 synergistically enhance the Sox9-dependent transcription. 
(A) Scx and E47 did not increase the luciferase activity of Gal4-TK Luc in the absence of Gal4-Sox9. 
The Gal4-TK Luc activity was stimulated up to a 3.2-fold level of control by Gal4-Sox9 1-507. No 
additional increase was observed by the single transfection of Scx or E47. However, a simultaneous 
transfection of Scx and E47 enhanced the Gal4-Sox9-dependent transcription to a 2.3-fold level of 
control. 
(B) Scx, E47, and p300 did not influence the activity of Gal4-Sox9 1-327 lacking the C-terminal 
transactivation domain. In the presence of Gal4-Sox9 1-507 (full length), Scx, E47, and p300 
synergistically stimulated the Sox9-dependent transcription to a 29-fold level of Gal4 control. 
(C) Activation domain (AD) 1/2 and bHLH domain of E47 were necessary for the synergistic increase 
of Sox9-dependent transcription in the presence of Scx and p300. No significant differences were 
observed between two hatched bars. * Statistical significances (p < 0.05) between the indicated bars. 
 
Fig. 4. E47 contributes to the indirect association between Scx and Sox9. 
(A) p300 associated with E47 and Sox9 in SW1353 cells. 
(B) E47 directly interacted with Sox9 even in the absence of p300. 
(C) FLAG-tagged Sox9 corresponding to 1-327 amino acids (Sox9 1-327) was not 
coimmunoprecipitated with E47. However, Sox9 1-423 and 182-507 directly associated with E47. 
(D) E47 formed a complex with Scx by its bHLH domain. 
(E) Cotransfection of E47 triggered the indirect association between Sox9 and Scx. 
* denotes a nonspecific band derived from IgG. 
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Fig. 5. Sox9, Scx, E47, and p300 cooperatively enhance the activity of native Col2a1 reporter 
genes. 
(A) Putative E-box sequences on Col2a1 promoters are shown as letters. Numbers indicate the 
distance from the transcription start site of each Col2a1 gene (National Center for Biotechnology 
Information: human, AC004801; rat, M10613; mouse, M65161). 
(B) Schematic illustrations of mouse Col2a1 reporter constructs. The site-directed mutant (capital 
letters) was used as pGL3-585M. The native Col2a1 enhancer, which contains the Sox9-binding 
sequence, was inserted into pGL3-585 as pGL3-585E (Furumatsu et al., 2009). 
(C) A simultaneous transfection of Scx and E47 increased the relative luciferase activity of pGL3-585 
up to a 2-fold level of untransfected control. However, Scx and E47 did not affect the activity of 
pGL3-585M and pGL3-569, which was inactivated or lacked the E-box sequence (-577 to -572 bp) of 
mouse Col2a1 promoter. 
(D) Scx and E47 cooperatively stimulated the activity of pGL3-585E to approximately 1.8-fold levels 
of each control. However, the synergistic effect of p300 was not observed in Sox9 1-327-transfected 
cells. Scx, E47, and p300 synergistically increased the activity of pGL3-585E up to a 4.3-fold level of 
control in the presence of Sox9 1-507. * Statistical significances (p < 0.05) between the indicated bars. 
 
Fig. 6. Scx-E47 associates with the conserved E-box of COL2A1 promoter on chromatin. 
(A) Transiently transfected Scx was detected in the nuclear fractions of SW1353 cells (Nuc). Small 
amounts of transfected Scx remained in the cytoplasmic fractions (Cyto). 
(B) Nuclear extracts as shown in (A) were used for EMSA. The conserved -577 E-box probes did not 
form protein-DNA complexes with the nuclear extracts of Scx or E47-single-transfected cells (Scx, 
E47). On the other hand, protein-DNA complexes were observed by using Scx and E47-cotransfected 
nuclear extracts (Scx + E47). Unlabeled -577 E-box probes (a 20-fold volume of labeled probes) 
decreased the complex formation between the Scx-E47-cotransfected nuclear extracts and labeled 
probes (Compete). Arrowhead and * denote the protein-DNA complex and free probes, respectively. 
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(C) The fragments, which include the conserved E-box, were coimmunoprecipitated with FLAG-
tagged Scx in chromatin IP analyses. The amplified fragments were detected in Scx and E47-
cotransfected cells, rather than in Scx-transfected cells (FLAG). Mouse IgG was used as a control for 
chromatin IP (IgG). A schema of human COL2A1 promoter and the conserved E-box are shown. 
Numbers indicate the distance from the transcription start site of COL2A1 gene (AC004801). Arrows 
denote the primer set for chromatin IP. 
 
Fig. 7. Sox9, Scx, E47, and p300 cooperatively regulate the Col2a1 gene expression. 
The schematic illustration of Col2a1 transactivation. Sox9 homodimer recognizes the Sox9-binding 
sequence (CATTCAT) on the Col2a1 enhancer in intron 1 (Bernard et al., 2003; Kamachi et al., 2000). 
Scx-E47 complex binds to the conserved E-box (CAGGTG) in the Col2a1 promoter. p300 acts as an 
important protein scaffold to connect Scx-E47 heterodimer with Sox9, and enhances the chromatin-
mediated transcription by its histone acetyltransferase activity (HAT). E47 also directly associates 
with Sox9 (Fig. 4C). The crosstalk among transcription factors (Sox9, Scx) and coactivators (E47, 
p300) has a critical role to induce the Col2a1 expression and chondrogenesis. Arrows denote the 
interactions between indicated molecules. Important domains for bindings and activations are shown. 
N, N-terminal. C, C-terminal. 
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Gene Species Sequences (5’-3’) Basepairs Source, Accession
SOX9 Human, Rat CTGAACGAGAGCGAGAAG
TTCTTCACCGACTTCCTCC
116 * NM_000346
SCX Human, Mouse TCTCCAAGATTGAGACGCTG
TCTGTTTGGGCTGGGTGTTC
201 * XM_926116
E47 Human, Rat ATGGGCTACCAGCTGCATGG
GAGTGATCCGGGGAGTAGAT
215 * NM_003200
COL2A1 Human AATTCCTGGAGCCAAAGGAT
AGGACCAGTTGCACCTTGAG
103 Kawakami et al.
G3PDH Human CATCAAGAAGGTGGTGAAGCAG
CGTCAAAGGTGGAGGAGTGG
119 Tetsunaga et al.
* GenBank accession numbers.
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